Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based TherapyPhuong K. Morrow, Francisco J. Esteva|Journal of Clinical Oncology|2011Cited by 211
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell CarcinomaSumanta K. Pal, Samer A. Srour, Lihua E. Budde et al.|Cancer Discovery|2024Cited by 137
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalitionBob T. Li, Yi‐Long Wu, Bobby Daly et al.|Nature Medicine|2022Cited by 52